ULTRAVIST 300 IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ultravist 300 In Plastic Container, and when can generic versions of Ultravist 300 In Plastic Container launch?
Ultravist 300 In Plastic Container is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in ULTRAVIST 300 IN PLASTIC CONTAINER is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ULTRAVIST 300 IN PLASTIC CONTAINER?
- What are the global sales for ULTRAVIST 300 IN PLASTIC CONTAINER?
- What is Average Wholesale Price for ULTRAVIST 300 IN PLASTIC CONTAINER?
Summary for ULTRAVIST 300 IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 11 |
Patent Applications: | 2,426 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ULTRAVIST 300 IN PLASTIC CONTAINER at DailyMed |
![ULTRAVIST 300 IN PLASTIC CONTAINER drug patent expirations Drug patent expirations by year for ULTRAVIST 300 IN PLASTIC CONTAINER](/p/graph/s/t/ULTRAVIST_300_IN_PLASTIC_CONTAINER-patent-expirations.png)
Recent Clinical Trials for ULTRAVIST 300 IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GE Healthcare | Phase 4 |
Bayer | Phase 4 |
Guerbet/Liebel-Flarsheim | Phase 4 |
Pharmacology for ULTRAVIST 300 IN PLASTIC CONTAINER
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for ULTRAVIST 300 IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | ULTRAVIST 300 IN PLASTIC CONTAINER | iopromide | INJECTABLE;INJECTION | 020220-005 | Nov 18, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ULTRAVIST 300 IN PLASTIC CONTAINER
See the table below for patents covering ULTRAVIST 300 IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 529565 | ⤷ Sign Up | |
Portugal | 70915 | ⤷ Sign Up | |
Philippines | 18301 | NOVEL TRIIODINATED ISOPHTHALIC ACID DIAMIDES AS NONIONIC X-RAY CONTRAST MEDIA | ⤷ Sign Up |
Egypt | 14530 | NON-IONIC X-RAY CONTRAST AGENTS | ⤷ Sign Up |
Germany | 3060434 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |